ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
26 announcements with these filters
Chemcrux Enterprises Ltd reported revenue from operations of ₹23.8 Cr (+34.5% YoY) and net profit of ₹0.5 Cr (+150.0% YoY) for Q2 FY27.
Chemcrux Enterprises approved unaudited standalone and consolidated results for Q1 and H1 FY27 at its November 2 board meeting. No financial figures are disclosed in this filing.
Chemcrux Enterprises intimated a Board Meeting scheduled for 02 November 2026 to approve unaudited financial results for Q2 and H1 FY2026-27. The trading window for insiders remains closed until 48 hours after results are published.
Chemcrux Enterprises Ltd has filed its quarterly shareholding pattern as mandated by SEBI regulations. This disclosure provides details on the company's equity structure and stakeholder ownership.
Chemcrux Enterprises Ltd regularised the appointment of Ms. Zarna Pankaj Thakar as an Independent Director for one year, effective August 4, 2026, per AGM approval.
Chemcrux Enterprises held its 30th Annual General Meeting on September 17, 2026. The meeting covered routine business, including financial statement approval and dividend declaration.
Mr. Bhanubhai Patel and Mr. Shailesh Patel have ceased to be Independent Directors of the Company following the completion of their second five-year tenure.
Chemcrux Enterprises Limited recommended a final dividend of Re. 1 per equity share for FY 2025-26. The payment follows the upcoming General Meeting.
Chemcrux Enterprises has fixed 10th September 2026 as the record date to ascertain eligibility for the final dividend to be declared at the 30th AGM.
Chemcrux Enterprises Limited has issued a notice for its 30th Annual General Meeting, scheduled to be held on September 17, 2026, via video conferencing.
Chemcrux Enterprises Ltd has submitted its Annual Report for the financial year 2025-26, which includes the notice for the 30th Annual General Meeting.
Chemcrux Enterprises Ltd appointed Ms. Zarna Pankaj Thakar as an Additional Director (Non-Executive, Independent), effective August 4, 2026, for a one-year term.
Chemcrux Enterprises Ltd reported revenue from operations of ₹21.9 Cr (+32.7% YoY) and net profit of ₹0.5 Cr (+400.0% YoY) for Q1 FY27.
Chemcrux Enterprises announced the approval of its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company also scheduled its 30th AGM.
Chemcrux Enterprises has scheduled a board meeting on 4th August 2026 to consider and approve its unaudited financial results for the quarter ending June 2026.
Chemcrux Enterprises incorporated Chemcrux Foundation as a wholly-owned Section 8 subsidiary. The company invested Rs. 0.01 Crore for 100% shareholding to fulfill CSR obligations.
Chemcrux Enterprises submitted its Annual Secretarial Compliance Report for FY2026. The report indicates full compliance with SEBI regulations, reflecting strong internal governance and regulatory adherence.
Chemcrux Enterprises granted 107,700 stock options to employees under ESOP 2025. This equity-linked incentive aligns employee interests with long-term shareholder value creation.
Chemcrux Enterprises subsidiary Kalichem Private Limited filed for regulatory approval to diversify into inorganic chemicals. The move expands operational scope at its Vadodara manufacturing facility.
Chemcrux Enterprises Ltd reported revenue from operations of ₹24.3 Cr (+54.8% YoY) and net profit of ₹1.8 Cr (+800.0% YoY) for Q4 FY26.
Chemcrux Enterprises reported standalone annual revenue of ₹82.58 Crore for FY2025-26. The Board recommended a 10% final dividend, reflecting steady financial performance and shareholder returns.
Chemcrux Enterprises approved FY26 audited results and recommended a 10% dividend. The board also approved incorporating a new wholly-owned non-profit subsidiary for CSR obligations.
Chemcrux Enterprises Ltd has scheduled a board meeting for May 14, 2026, to approve audited financial results for the quarter and year ended March 31, 2026. The board will also consider recommending a final dividend for FY 2025-26. The company's trading window remains closed until 48 hours after the results declaration.
Chemcrux Enterprises Ltd confirmed it is not a 'Large Corporate' as of March 31, 2026, under SEBI's debt-raising framework. The company reported outstanding borrowings of ₹17.88 Crore. This routine disclosure clarifies that the company is not subject to mandatory incremental borrowing through debt securities.
Chemcrux Enterprises Ltd clarified to BSE that recent share price movement is purely market-driven. The company confirmed all price-sensitive information has been duly disclosed under Regulation 30 of SEBI LODR Regulations. Management stated no material events or information have been withheld from the exchange.
Chemcrux Enterprises Ltd submitted its quarterly certificate under SEBI (DP) Regulations for the period ended March 31, 2026. The registrar confirmed that all shares are in dematerialised form and no rematerialisation requests were received during the quarter.